NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New South Wales (NSW). The NSW Cannabis Medicines Advisory Service (CMAS) provides expert clinical guidance and support to medical practitioners considering prescribing a cannabis medicine to their patient(s). Aims: This research examines quality assurance and patient outcomes related to enquirers’ experience with NSW CMAS. Methods: Data collection involved an online, anonymous survey with two components. Following a health professional enquiry, quality
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in